We are still transitioning from our old blog, so pardon our dust. To contact the Mesothelioma Applied Research Foundation or for immediate help with your questions, you can reach us by phone at 877.363.6376.
Vivace Therapeutics Receives FDA Orphan Drug Designation for VT3989 for Mesothelioma Treatment
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental
